US Market Report for Detachable Coils 2017 - MedCore
Coiling has emerged as the primary treatment method for aneurysms and continues to replace aneurysm clipping. The transition from clipping to coiling led to rapid market growth market early in the century but coiling is forecasted to reach its saturation point in the next few years. The market comprises bare platinum and coated detachable coils. Although coated coils sell for a premium, their adoption has been limited due to a lack of evidence of their superiority when compared to bare platinum coils. Trials such as the MAPS and Cerecyte failed to show a superior efficacy for coated coils over bare platinum coils and as a result the use of coated coils has been decreasing. It is estimated that 90% of total unit sales of coils are bare platinum coils and that this trend will continue unless clinical evidence demonstrates health benefits from coated coils.
Detachable coil embolization is a minimally invasive method of treating brain aneurysms and cerebral blood vessel malformations. The detachable coil embolization treatment of cerebral aneurysms is less invasive and requires less recovery time than open surgery. An aneurysm is a weakened area in the wall of an artery in the brain. This area bulges in the artery and if it ruptures it can lead to a bleed in the brain and cause stroke, brain damage and even death. Interventional neuroradiologists will typically perform the detachable coil embolization process to alleviate dangers associated with aneurysms.